Clinical Trial Update: Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from AgonOx is evaluating cancer-specific CD8+ TIL-based adoptive cell therapy in adults with solid tumors, including head and neck squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gynecologic Cancer
• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Melanoma
• Urogenital Cancer

Drugs mentioned

• Adoptive Cell Therapy using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes

Snippet

Sponsor: AgonOx, Inc. | Conditions: HNSCC, Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING